Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Agilon Health (AGL) Non Operating Income (2020 - 2025)

Agilon Health's Non Operating Income history spans 6 years, with the latest figure at $41.0 million for Q4 2025.

  • For Q4 2025, Non Operating Income rose 433.27% year-over-year to $41.0 million; the TTM value through Dec 2025 reached $67.6 million, up 96.05%, while the annual FY2025 figure was $67.6 million, 96.05% up from the prior year.
  • Non Operating Income reached $41.0 million in Q4 2025 per AGL's latest filing, up from $9.4 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $41.0 million in Q4 2025 to a low of -$1.9 million in Q4 2021.
  • Average Non Operating Income over 5 years is $7.7 million, with a median of $7.0 million recorded in 2022.
  • The largest YoY upside for Non Operating Income was 4109.46% in 2021 against a maximum downside of 164.31% in 2021.
  • A 5-year view of Non Operating Income shows it stood at -$1.9 million in 2021, then soared by 507.49% to $7.6 million in 2022, then fell by 1.65% to $7.4 million in 2023, then grew by 3.46% to $7.7 million in 2024, then skyrocketed by 433.27% to $41.0 million in 2025.
  • Per Business Quant, the three most recent readings for AGL's Non Operating Income are $41.0 million (Q4 2025), $9.4 million (Q3 2025), and $7.9 million (Q2 2025).